s6y
Company name or ticker
Search
Ally Bridge Group Innovation Capital Partners III, L.P.
4
Sorrento Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
Filed
Wednesday, February 7, 2018
Period
Feb 5, 2018
Accession number
0001209191-18-008030
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header